Cargando…

Selective Anti-Proliferation of HER2-Positive Breast Cancer Cells by Anthocyanins Identified by High-Throughput Screening

Overexpressed Human epidermal growth factor receptor 2 (HER2) drives the biology of 20% breast cancer and is a prediction of a poor prognosis for patients. HER2-targeted therapies significantly improve outcomes for HER2-positive patients. Traditional Chinese herbs/medicines have been used to treat b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Weihua, Xu, Jinmei, Wu, Shaoping, Liu, Yilun, Yu, Xiaoping, Chen, Juan, Tang, Xi, Wang, Zhi, Zhu, Xiaohu, Li, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849376/ https://www.ncbi.nlm.nih.gov/pubmed/24312561 http://dx.doi.org/10.1371/journal.pone.0081586

Ejemplares similares

Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation
por: Sun, Jiangang, et al.
Publicado: (2020)

Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment
por: Yang, Liu, et al.
Publicado: (2022)

High-throughput small molecule screen identifies inhibitors of microsporidia invasion and proliferation in C. elegans
por: Murareanu, Brandon M., et al.
Publicado: (2022)

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
por: Normann, Lisa Svartdal, et al.
Publicado: (2023)

High-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis
por: Alkhilaiwi, Faris, et al.
Publicado: (2019)

CD40×HER2 bispecific antibody overcomes the CCL2-induced trastuzumab resistance in HER2-positive gastric cancer
por: Sun, Weilin, et al.
Publicado: (2022)

AK4 Promotes the Progression of HER2-Positive Breast Cancer by Facilitating Cell Proliferation and Invasion
por: Zhang, Jie, et al.
Publicado: (2019)

Yeast-based automated high-throughput screens to identify anti-parasitic lead compounds
por: Bilsland, Elizabeth, et al.
Publicado: (2013)

Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screening
por: Benítez, Diego, et al.
Publicado: (2022)

Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer
por: Zhao, Shen, et al.
Publicado: (2019)

High throughput cytotoxicity screening of anti-HER2 immunotoxins conjugated with antibody fragments from phage-displayed synthetic antibody libraries
por: Hou, Shin-Chen, et al.
Publicado: (2016)

High-throughput phenotypic screen identifies a new family of potent anti-amoebic compounds
por: Sauvey, Conall, et al.
Publicado: (2023)

Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
por: Stanowicka-Grada, Malwina, et al.
Publicado: (2023)

High-Throughput Screening Identifies Idarubicin as a Preferential Inhibitor of Smooth Muscle versus Endothelial Cell Proliferation
por: Goel, Shakti A., et al.
Publicado: (2014)

HER2-positive gastric cancer identified by serum HER2: A case report
por: SAITO, MAYUKO, et al.
Publicado: (2016)

USP8 Inhibitor Suppresses HER-2 Positive Gastric Cancer Cell Proliferation and Metastasis via the PI3K/AKT Signaling Pathway
por: Sun, Jiangang, et al.
Publicado: (2020)

Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes
por: Salas-Sarduy, Emir, et al.
Publicado: (2017)

High-Throughput Screening of a Marine Compound Library Identifies Anti-Cryptosporidium Activity of Leiodolide A
por: Bone Relat, Rachel M., et al.
Publicado: (2022)

(131)I-Labeled Anti-HER2 Nanobody for Targeted Radionuclide Therapy of HER2-Positive Breast Cancer
por: Zhao, Lingzhou, et al.
Publicado: (2023)

Correction: High-Throughput Screening Identifies Idarubicin as a Preferential Inhibitor of Smooth Muscle versus Endothelial Cell Proliferation
Publicado: (2014)

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
por: Morsberger, Laura, et al.
Publicado: (2022)

Pyrotinib for Elderly Patients with Advanced HER2-Positive Breast Cancer
por: Li, Yan, et al.
Publicado: (2022)

New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified
por: MacNeil, Ian A., et al.
Publicado: (2020)

Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer
por: Xie, Yifan, et al.
Publicado: (2021)

High-Throughput Small Molecule Screen Identifies Modulators of Mitochondrial Function in Neurons
por: Varkuti, Boglarka H., et al.
Publicado: (2020)

High-Throughput Small Molecule Screen Identifies Modulators of Mitochondrial Function in Neurons
por: Varkuti, Boglarka H., et al.
Publicado: (2020)

A high-throughput chemical screen identifies novel inhibitors and enhancers of anti-inflammatory functions of the glucocorticoid receptor
por: Jiang, Xiaofeng, et al.
Publicado: (2017)

Development of a High-Throughput Cytometric Screen to Identify Anti-Wolbachia Compounds: The Power of Public–Private Partnership
por: Clare, Rachel H., et al.
Publicado: (2019)

High throughput screening identifies modulators of histone deacetylase inhibitors
por: Gaupel, Ann-Christin, et al.
Publicado: (2014)

High-throughput chromatin screens to identify targets of senescence and aging
por: Sen, Payel
Publicado: (2020)

Statistical models for identifying frequent hitters in high throughput screening
por: Goodwin, Samuel, et al.
Publicado: (2020)

Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer
por: Maddox, Adam L., et al.
Publicado: (2022)

A High Throughput Screen Identifies Nefopam as Targeting Cell Proliferation in β-Catenin Driven Neoplastic and Reactive Fibroproliferative Disorders
por: Poon, Raymond, et al.
Publicado: (2012)

Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
por: Atallah, N. M., et al.
Publicado: (2023)

A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer
por: Yalikong, Ayimukedisi, et al.
Publicado: (2021)

The strawberry transcription factor FaRAV1 positively regulates anthocyanin accumulation by activation of FaMYB10 and anthocyanin pathway genes
por: Zhang, Zuying, et al.
Publicado: (2020)

Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death
por: Zhu, Ping Jun, et al.
Publicado: (2009)

Black rice-derived anthocyanins inhibit HER-2-positive breast cancer epithelial-mesenchymal transition-mediated metastasis in vitro by suppressing FAK signaling
por: Zhou, Jie, et al.
Publicado: (2017)

Small Molecule Regulators of microRNAs Identified by High-Throughput Screen Coupled with High-Throughput Sequencing
por: Krichevsky, Anna, et al.
Publicado: (2023)

Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing
por: Nguyen, Lien D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o23i0gqqrmd2v8dl7cpo0l38rl